Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 15;1(2):e000010.
doi: 10.1136/bmjgh-2015-000010. eCollection 2016.

Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades

Affiliations

Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades

Jacob Levi et al. BMJ Glob Health. .

Abstract

Background: In 2014, the Joint United Nations Programme on HIV and AIDS (UNAIDS) and partners set the '90-90-90 targets'; aiming to diagnose 90% of all HIV positive people, provide antiretroviral therapy (ART) for 90% of those diagnosed and achieve viral suppression for 90% of those treated, by 2020. This results in 81% of all HIV positive people on treatment and 73% of all HIV positive people achieving viral suppression. We aimed to analyse how effective national HIV treatment programmes are at meeting these targets, using HIV care continuums or cascades.

Methods: We searched for HIV treatment cascades for 196 countries in published papers, conference presentations, UNAIDS databases and national reports. Cascades were constructed using reliable, generalisable, recent data from national, cross-sectional and longitudinal study cohorts. Data were collected for four stages; total HIV positive people, diagnosed, on treatment and virally suppressed. The cascades were categorised as complete (four stages) or partial (3 stages), and analysed for 'break points' defined as a drop >10% in coverage between consecutive 90-90-90 targets.

Results: 69 country cascades were analysed (32 complete, 37 partial). Diagnosis (target one-90%) ranged from 87% (the Netherlands) to 11% (Yemen). Treatment coverage (target two-81% on ART) ranged from 71% (Switzerland) to 3% (Afghanistan). Viral suppression (target three-73% virally suppressed) was between 68% (Switzerland) and 7% (China).

Conclusions: No country analysed met the 90-90-90 targets. Diagnosis was the greatest break point globally, but the most frequent key break point for individual countries was providing ART to those diagnosed. Large disparities were identified between countries. Without commitment to standardised reporting methodologies, international comparisons are complex.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Compares the UNAIDS targets for 2020 with global estimates for 2014/15.
Figure 2
Figure 2
A(i) Percentage of total HIV positive people receiving diagnosis for 32 countries with full cascades. A(ii) Percentage of total HIV positive people receiving diagnosis for 23 countries with partial cascades. B(i) Percentage of total HIV positive people receiving ART for 32 countries with full cascades. B(ii) Percentage of total HIV positive people receiving ART for 34 countries with partial cascades. C(i) Percentage of total HIV positive people achieving undetectable HIV RNA for 32 countries with full cascades. C(ii) Percentage of total HIV positive people achieving undetectable HIV RNA for 12 countries with partial cascades.
Figure 2
Figure 2
Continued
Figure 3
Figure 3
(A) Target 1 vs Target 2 - % of those diagnosed vs % of those diagnosed receiving ART. (B) Target 2 vs Target 3 - % of those diagnosed on ART vs % of those on ART achieving viral suppression.

References

    1. The Joint United Nations Programme on HIV/AIDS. 90–90-90 An ambitious treatment target to help end the AIDS epidemic. 2014;JC2684. http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf
    1. Lundgren JD, Babiker AG, Gordin F et al. , The INSIGHT START Study Group. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med 2015;373:795–807.10.1056/NEJMoa1506816 - DOI - PMC - PubMed
    1. Cohen MS, Chen YQ, McCauley M et al. . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505. 10.1056/NEJMoa1105243 - DOI - PMC - PubMed
    1. Gruskin S, Tarantola D. Universal Access to HIV prevention, treatment and care: assessing the inclusion of human rights in international and national strategic plans. AIDS 2008;22(Suppl 2):S123–32. 10.1097/01.aids.0000327444.51408.21 - DOI - PMC - PubMed
    1. Gardner EM, McLees MP, Steiner JF et al. . The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011;52:793–800. 10.1093/cid/ciq243 - DOI - PMC - PubMed

LinkOut - more resources